<PAGE>

                                                                    EXHIBIT 31.1

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                      AS ADOPTED PURSUANT TO SECTION 302 OF
                         THE SARBANES-OXLEY ACT OF 2002

      I, L. B. (Brad) Clarke, certify that:

      1. I have  reviewed  this  quarterly  report on Form 10-QSB of  Organetix,
         Inc.;

      2. Based on my  knowledge,  this  quarterly  report  does not  contain any
      untrue  statement  of a  material  fact or omit to state a  material  fact
      necessary to make the statements made, in light of the circumstances under
      which such statements were made, not misleading with respect to the period
      covered by this quarterly report;

      3. Based on my knowledge,  the financial  statements,  and other financial
      information  included  in this  quarterly  report,  fairly  present in all
      material respects the financial condition,  results of operations and cash
      flows of the  registrant  as of, and for,  the periods  presented  in this
      quarterly report;

      4. I am responsible for establishing and maintaining  disclosure  controls
      and  procedures  (as defined in Exchange  Act Rules 13a-14 and 15d-14) for
      the  registrant  and  have:

            a) designed such  disclosure  controls and procedures to ensure that
            material  information  relating  to the  registrant,  including  its
            consolidated  subsidiaries,  is made  known to us by  others  within
            those  entities,  particularly  during  the  period  in  which  this
            quarterly report is being prepared;

            b)  evaluated  the  effectiveness  of  the  registrant's  disclosure
            controls  and  procedures  as of a date  within 90 days prior to the
            filing date of this quarterly report (the "Evaluation Date"); and

            c)  presented  in this  quarterly  report my  conclusions  about the
            effectiveness of the disclosure controls and procedures based on our
            evaluation as of the Evaluation Date;

      5. I  have  disclosed,  based  on  our  most  recent  evaluation,  to the
      registrant's  auditors and the audit  committee of  registrant's  board of
      directors  (or  persons  performing  the  equivalent  functions):

            a) all  significant  deficiencies  in the  design  or  operation  of
            internal  controls  which could  adversely  affect the  registrant's
            ability to record, process,  summarize and report financial data and
            have   identified  for  the   registrant's   auditors  any  material
            weaknesses in internal  controls;  and

            b) any fraud,  whether or not material,  that involves management or
            other  employees  who have a  significant  role in the  registrant's
            internal controls; and

      6. I have  indicated in this  quarterly  report  whether or not there were
      significant  changes in internal  controls or in other  factors that could
      significantly  affect internal controls  subsequent to the date of my most
      recent  evaluation,  including  any  corrective  actions  with  regard  to
      significant deficiencies and material weaknesses.


      Date: May 10, 2004


      /s/ L. B. (Brad) Clarke
      ------------------------
      Name:  L. B. (Brad)  Clarke
      Title:  President and Chief Financial Officer